• DOI:10.1056/NEJMoa0800742
Corpus ID: 8085257

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

@article{Kastelein2008SimvastatinWO,
  title={Simvastatin with or without ezetimibe in familial hypercholesterolemia.},
  author={J. Kastelein and F. Akdim and E. Stroes and A. Zwinderman and M. Bots and A. Stalenhoef and F. Visseren and E. Sijbrands and M. Trip and E. Stein and D. Gaudet and R. Duivenvoorden and E. Veltri and A. D. Marais and E. de Groot},
  journal={The New England journal of medicine},
  year={2008},
  volume={358 14},
  pages={
          1431-43
        }
}

• J. Kastelein, F. Akdim, +12 authors E. de Groot
• Published 2008
• Medicine
• The New England journal of medicine

BACKGROUND Ezetimibe, a cholesterol-absorption inhibitor, reduces levels of low-density lipoprotein (LDL) cholesterol when added to statin treatment. However, the effect of ezetimibe on the progression of atherosclerosis remains unknown. METHODS We conducted a double-blind, randomized, 24-month trial comparing the effects of daily therapy with 80 mg of simvastatin either with placebo or with 10 mg of ezetimibe in 720 patients with familial hypercholesterolemia. Patients underwent B-mode… Expand

View on PubMed

columbia.edu

Save to Library

Create Alert

Cite

Launch Research Feed